Abstract
The global antimicrobial resistance (AMR) emergency is driven by complex and evolving molecular mechanisms. Cutting-edge machine learning methods and multiomics technologies can help to combat this crisis by predicting novel AMR biomarkers and outcomes with unprecedented precision and speed, offering critical insights into the molecular underpinnings of AMR.